Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA
Original Paper
[키워드] administration
anti-RBD
anti-SARS-CoV-2
anti-SARS-CoV-2 antibody
antibodies
antibody
antitela
Baseline assessment
Beckman Coulter
BNT162b2 mRNA
BNT162b2 mRNA COVID-19 vaccine
BNT162b2 mRNA Covid-19 vakcina
Consensus
coronavirus disease
correlation
COVID-19
COVID-19 vaccination
Cutoff
DiaSorin
dose
effective
evaluated
FIVE
fixed
healthcare
IgG
immune response
immunoassay
immunoassays comparison
imuni odgovor
interval
median
mitigate
mRNA
mRNA vaccine
neutralizing antibody
Neutralizing antibody response
of BNT162b2
Pfizer
poređenje imunoodređivanja
Post-vaccine
ranged
receiving
Receptor binding domain
Result
Roche
SNIBE
Spearman
spike trimer
study period
subject
the immunoassay
the mean
Total
total antibody
vaccination
Vaccine
vaccine dose
venous blood
was collected
[DOI] 10.5937/jomb0-31475 PMC 바로가기 [Article Type] Original Paper
[DOI] 10.5937/jomb0-31475 PMC 바로가기 [Article Type] Original Paper